{
  "docId": "019dd923-5ca1-7489-b638-4862bdde324a",
  "docSlug": "88d99bc6679a37b8",
  "documentTitle": "What is and how to navigate the RAS opportunity in LatAm?",
  "authorId": "LEK",
  "authorName": "L.E.K.",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 12,
  "pageCount": 17,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "market_landscape",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The chart uses a grid-based timeline to represent months, with color-coded bars indicating current approval times and potential reduction intervals.",
  "elementsJson": [
    "headline_text",
    "data_table",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-4862bdde324a/12",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-4862bdde324a",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-4862bdde324a.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-4862bdde324a#slide-12",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Current registration timeframe may be potentially reduced due to expected approval of Anvisa's reliance programs with international agencies",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-c7cb-728d-8e5e-2695f4ba8da0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.95,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Timeline of approval months by country",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "812b0dc1-af42-41c5-b6fb-5bfce852a04e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.03,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "Note: 1) expected times are the medians of intervals for each country. Source: L.E.K. research and analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1fd7b421-9c1d-4509-9131-fc9d03178724",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.23,
        "x": 0.61,
        "y": 0.091
      },
      "kind": "legend",
      "text": "Potential harmonization time reduction",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "472a5bb9-562a-4bca-8f80-a62085768d8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Months to approval",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-c7cb-728d-8e5e-2a05b1a47540",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "RAS devices expected approval times¹ in Latin America",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80dd634b-89f5-438f-8ef7-d2fddd634a81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Regulatory landscape is supportive of novel technologies, not demanding clinical trials by specialty, allowing for fast market entry",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a9677cc-e7df-4919-be48-e928b53eb4a4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 11,
      "beatId": "5f25bce4-1a09-4d87-95e5-221c514d607f",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Market opportunity and L.E.K.'s expertise",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}